Back to results
US 12,692,513 B2Granted
Prostate neoantigens and their uses
AssigneeJanssen Biotech, Inc.
InventorsJason Lee DeHart, Vipul Bhargava, Patrick Wilkinson, Manuel Alejandro Sepulveda
Life of this patent
Estimating the term…
Abstract
Disclosed herein are self-replicating RNA molecules encoding prostate neoantigens, vaccines, and method of treating and preventing prostate cancer using the self-replicating RNA molecules and vaccines.
Claims9
A method of treating a prostate cancer in a subject, the method comprising administering to the subject:
- a) first vaccine comprising an Ad26 vector comprising a polynucleotide encoding the polypeptides of SEQ ID NOs:
- 275, 381, 333, 337, 269, 253, 309, 325, 271, 305, 251, 245, 261, 265, 317, 255, 297, 285, 437, 439, 442, 444, 379, 343, 211, 349, 213, 215, 221, 219, 225, 345, 353, 235, 223, 167, 171, 19, 23, and 177;
- and
- b) a second vaccine comprising a self-replicating RNA molecule comprising a polynucleotide encoding the polypeptides of SEQ ID NOs:
- 275, 381, 333, 337, 269, 253, 309, 325, 271, 305, 251, 245, 261, 265, 317, 255, 297, 285, 437, 439, 442, 444, 379, 343, 211, 349, 213, 215, 221, 219, 225, 345, 353, 235, 223, 167, 171, 19, 23, and 177.
2 more elements
Dependencies are inferred from the claim text.